FINWIRES · TerminalLIVE
FINWIRES

Telix Pharmaceuticals, United Imaging Healthcare Sign MOU for US Theranostics Collaboration

By

Telix Pharmaceuticals (ASX:TLX) and United Imaging Healthcare North America entered into a memorandum of understanding (MOU) to evaluate a strategic research partnership in the US focused on developing integrated theranostics technologies that combine diagnostics and targeted therapy, Telix said Tuesday after hours.

The partnership will evaluate integrating United Imaging's imaging systems, software, connectivity, and artificial intelligence (AI) tools with the company's molecular imaging portfolio and clinical protocols to enhance theranostic workflows.

Key focus areas include improving integration of imaging and radiopharmaceutical workflows, standardizing protocol-driven imaging across sites, enhancing treatment planning and patient monitoring, and developing AI-enabled clinical decision support tools.

The initial focus will be on TLX101-Px, a positron emission tomography imaging candidate, with opportunities to expand into additional products and markets, as well as pilot programs and protocol optimization efforts.

Related Articles

Asia

Peter Warren Automotive Holdings' Wakeling Deal Faces ACCC Phase Two Competition Review

Peter Warren Automotive Holdings' (ASX:PWR) planned purchase of 30 new car dealership sites from Wakeling Automotive Group will undergo a detailed phase two Australian Competition and Consumer Commission (ACCC) review after the competition regulator raised concerns about the deal's potential impact on market competition, according to an Australian bourse filing on Tuesday after market hours.The regulator did not approve the acquisition during its phase one assessment, saying that the merged company would own 25 of the region's 33 new car dealerships, per the filing. It is assessing how the deal could affect competition in new vehicle sales, as well as servicing and repair services.The ACCC has yet to make a final decision and is inviting public submissions until June 16, the filing added. The phase two review could take up to 90 business days.In a separate filing, Peter Warren Automotive said the companies will continue to work with the ACCC to address any concerns arising during the phase two review.

$ASX:PWR
Asia

Nova Minerals Says New South Wales Court Approves New US Holding Entity Plan

Nova Minerals (ASX:NVA) said the Supreme Court of New South Wales has approved its proposed schemes of arrangement, enabling newly formed Nova Minerals Corp to acquire all existing shares and Nasdaq-listed warrants and become the group's new US-based holding entity, according to an Australian bourse filing on Tuesday after market hours.The schemes are expected to take legal effect on Wednesday upon lodgment of the court orders with the Australian Securities and Investments Commission, after which the company shares are anticipated to be suspended from trading on the Australian Securities Exchange, the filing added.

$ASX:NVA
Asia

Correction: Alcoa Says Tin Included in 2025 Conflict Minerals Report Either Not from Covered Countries or Scrap/Recycled Materials

(Corrects reference to the report in the first paragraph and updates throughout to include more details)Alcoa (ASX:AAI) concluded in its 2025 Conflict Minerals Disclosure report that the tin included in its products either did not originate in the Democratic Republic of the Congo or adjoining countries or from scrap or recycled materials.The company made the disclosure in a SEC filing dated May 29 and published on the Australian bourse Monday as it found that one supplier was likely to have supplied Conflict Minerals during the reporting year.Conflict minerals include coltan, cassiterite, gold, wolframite, and the derivatives tantalum, tin, and tungsten, according to the Form SD Specialized Disclosure Report.

$ASX:AAI